Showing 61-80 of 746 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Anticonvulsants for neonates with seizures
Cochrane Systematic Reviews, 11-Nov-2008
Neonatal seizures are a common problem and most neonates with seizures are treated with anticonvulsants. There is wide variation in clinical practice in both diagnosis and treatment of such seizures and this reflects the lack of clear evidence of the rela
- Anticonvulsants for preventing seizures in patients with chronic subdural haematoma
Cochrane Systematic Reviews, 6-Jun-2013
Anticonvulsant therapy is sometimes used prophylactically in patients with chronic subdural haematoma, although the benefit is unclear.
- Anti‐D administration in pregnancy for preventing Rhesus alloimmunisation
Cochrane Systematic Reviews, 3-Sep-2015
During pregnancy, a Rhesus negative (Rh-negative) woman may develop antibodies when her fetus is Rhesus positive (Rh-positive). These antibodies may harm Rh-positive babies.
- Antidepressant drugs for narcolepsy
Cochrane Systematic Reviews, 11-May-2010
This is an updated version of the original Cochrane review published in Issue 1, 2008.
- Antidepressant treatment for postnatal depression
Cochrane Systematic Reviews, 11-Sep-2014
Postnatal depression is a common disorder that can have adverse short- and long-term effects on maternal morbidity, the new infant and the family as a whole. Treatment is often largely by social support and psychological interventions. It is not known whe
- Antidepressants for anorexia nervosa
Cochrane Systematic Reviews, 31-Oct-2008
Anorexia Nervosa (AN) is an illness characterised by extreme concern about body weight and shape, severe self-imposed weight loss, and endocrine dysfunction. In spite of its high mortality, morbidity and chronicity, there are few intervention studies on t
- Antidepressants for depressed elderly
Cochrane Systematic Reviews, 25-Jan-2006
Depression is a relatively common experience in older adults. The syndrome is associated with considerable distress, morbidity and service commitment. Approximately two thirds of patients presenting with severe forms will respond to antidepressant treatme
- Antidepressants for generalised anxiety disorder (GAD)
Cochrane Systematic Reviews, 10-Mar-2016
Pharmacological treatments have been successfully used to treat Generalized Anxiety Disorder (GAD). Benzodiazepine and non benzodiazepine anxiolytics used to be the mainstay for the pharmacological treatment of GAD. However, data emerging over the last tw
- Antidepressants for neuropathic pain
Cochrane Systematic Reviews, 27-Jan-2014
This is an updated version of the original Cochrane review published in Issue 3, 2005 of The Cochrane Library
. For many years antidepressant drugs have been used to manage neuropathic pain, and are often the first choice treatment. It is not clear, howev
- Antidepressants for non‐specific low back pain
Cochrane Systematic Reviews, 23-Jan-2008
Antidepressants are commonly used in the management of low-back pain. However, their use is controversial.
- Antidepressants for patients with tinnitus
Cochrane Systematic Reviews, 12-Sep-2012
This is an update of a Cochrane review first published in The Cochrane Library in Issue 4, 2006 and previously updated in 2009.
- Antidepressants for preventing postnatal depression
Cochrane Systematic Reviews, 18-Apr-2018
Depression is common in the postnatal period and can lead to adverse effects on the infant and wider family, in addition to the morbidity for the mother. It is not clear whether antidepressants are effective for the prevention of postnatal depression and
- Antidepressants for smoking cessation
Cochrane Systematic Reviews, 22-Apr-2020
Whilst the pharmacological profiles and mechanisms of antidepressants are varied, there are common reasons why they might help people to stop smoking tobacco. Firstly, nicotine withdrawal may produce depressive symptoms and antidepressants may relieve the
- Antidepressants for the negative symptoms of schizophrenia
Cochrane Systematic Reviews, 26-Apr-2012
Negative symptoms are common in people with schizophrenia and are often difficult to treat with antipsychotic drugs. Treatment often involves the use of various add-on medications such as antidepressants.
- Antidepressants for treating depression in dementia
Cochrane Systematic Reviews, 31-Aug-2018
The use of antidepressants in dementia accompanied by depressive symptoms is widespread, but their clinical efficacy is uncertain. This review updates an earlier version, first published in 2002.
- Antidepressants plus benzodiazepines for adults with major depression
Cochrane Systematic Reviews, 3-Jun-2019
Anxiety frequently coexists with depression and adding benzodiazepines to antidepressant treatment is common practice to treat people with major depression. However, more evidence is needed to determine whether this combined treatment is more effective an
- Antidepressants versus placebo for people with bulimia nervosa
Cochrane Systematic Reviews, 20-Oct-2003
Bulimia Nervosa (BN) represents an important public health problem and is related to serious morbidity and even mortality. This review attempted to systematically evaluate the use of antidepressant medications compared with placebo for the treatment of bu
- Antidepressants versus placebo for the depressed elderly
Cochrane Systematic Reviews, 22-Jan-2001
Depression warranting intervention is found in ten percent of people over the age of 60. Older depressed people are more likely to die than non-depressed. Relatively few receive therapeutic interventions, and those that do, tend to receive low dose antide
- Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis
Cochrane Systematic Reviews, 21-Apr-2016
Intracranial venous thrombosis (ICVT) commonly presents with seizures in the acute period, and some people may develop recurrent seizures in the long term. The prophylactic use of antiepileptic drugs (AEDs) for the management of post-ICVT seizures is cont
- Antiepileptics for aggression and associated impulsivity
Cochrane Systematic Reviews, 17-Feb-2010
Aggression is a major public health issue and is integral to several mental health disorders. Antiepileptic drugs may reduce aggression by acting on the central nervous system to reduce neuronal hyper-excitability associated with aggression.
